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Cannabis use among teenagers in Canada is a concern because of the long-term and 
irreversible effects cannabis has on the developing body and mind. Nurses can be 
instrumental in screening for cannabis abuse by implementing a tool to assess for 
substance use disorder (SUD) and triage drug users to appropriate treatment. This project 
focused on how to implement the CRAFFT screening tool while gaining insight of the 
practitioner’s knowledge base about the tool and how SUD is being screened for, 
currently. The CRAFFT screening tool aligns with the DSM-IV’s SUD diagnosis criteria, 
allowing for efficient identification of those at risk for SUDs. Rotter’s social-behavioral 
learning theory is presented to provide a greater understanding of how one’s environment 
affects SUDs. Sources of evidence were primary health care providers (N = 10) at the 
health center where this project was conducted. Data were collected before and after the 
participants engaged in the learning module on the CRAFFT screening tool. Descriptive 
analysis found that being acquainted with the tool allowed health care providers to 
understand the significance of screening for cannabis use among young adults and 
teenagers and to have more detailed documentation of patients’ relationships with 
cannabis. The screening tool was favored by 90% of the participants for cannabis use 
assessment after learning about the tool with this project.  Nine out of ten of the 
participants indicated that they will now use the tool to aide in identifying SUD. Once 
SUD has been identified with the use of the CRAFFT screening tool, 80% of the 
participants indicated that they would refer their patients for further assessment and 
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Section 1: Implementation of CRAFFT Screening Tool 
Introduction 
Many medical doctors prescribe medical marijuana commonly to aide in chronic 
medical conditions (College of Physicians and Surgeons, 2016).  However, the long-term 
and short-term effects of recreational cannabis on adolescent body and minds can hinder 
ongoing development of the maturing brain (Center of Addiction and Mental Health, 
2017).  With the legalization of recreational cannabis occurring at a rapid pace in North 
America, there is also an increase in new growing methods of the plant that has allowed 
for higher potencies leading to an increase in substance use disorders (SUDs) (Teen 
Challenge, 2015).  Another major concern of the legalization of recreational marijuana is 
the lack of being accountable for the potential risks associated with this controversial 
drug (Khamsi, 2013).  Adverse effects of cannabis include but are not limited to motor 
vehicle crashes, cardiovascular and respiratory disease, effects on physical development, 
and, effects on mental health (Khamsi, 2013).  Cannabis use is strongly associated with 
poorer educational end points as well as being an entry drug that leads users to other 
harsher illicit drug use (Hall, 2009).   
In Ontario, the Center for Addiction and Mental Health (CAMH) conducts a 
population survey of thousands of Ontario students, titled the Ontario Student Drug Use 
and Health Survey, which were established in 1977 (Center for Addiction and Mental 
Health, 2017).  This self-administered survey is distributed every 2 years to students in 
grades 7 through 12 with the purpose of capturing trends in this population related to 
drug use, mental health, physical health, gambling, bullying, and other risky behaviors 
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(CAMH, 2017).  Information from this survey provides reliable information about 
adolescents’ current health risk behaviors along with their attitudes and beliefs about 
health care (CAMH, 2017).  Health, education, and government officials use these 
findings to aid in creating health priorities and preventative policies to address youth’s 
needs (CAMH, 2017).  Most current information is from 2015 (CAMH, 2017).  The top 
four substances used by Ontario students are alcohol (58%), cannabis (25%), non-
prescribed opioids (17%), and tobacco (11%) (CAMH, 2017).   
When asked if in the past year they had been offered, sold or given a drug at 
school, 23% of Ontario students answered yes, which equates to approximately 219,000 
students (Teen challenge, 2015).  Canada’s adolescent and young adult drug users 
account for 60% of all drug users in the country.  Of these drug users 47,000 die from 
drug-related causes on an annual basis (Teen Challenge, 2015).    
Marijuana use among youth and young adults is 22% and 26% respectively 
according to a 2013 poll (Canadian Centre on Substance Abuse, 2016).  When compared 
to adult use, this proved to be two and a half times more, with adults 25 years and older 
ranking at 8% (CCSA, 2016).  Governing States and Localities reports, as of November 
11, 2016, that 26 states in the United States plus the District of Columbia are addressing 
the legalization of marijuana in some form, with seven of these 28 locations legalizing 
cannabis for recreational use (Government of Canada, 2017).  These laws pertain to those 
21 years of age and older.  Canada’s Task Force on Legalization and Regulation is 
addressing the legalization of cannabis (Government of Canada, 2017).  In a November, 
2016 report by the Government of Canada (2017) Task Force on Legalization and 
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Regulation, the Canadian government has predicted that cannabis will be legalized for 
recreational use across the country by summer 2018.   
CRAFFT, a cannabis use screening tool, is one of three tools that can be used to 
aid in identifying adolescents at risk for the adverse effects of cannabis use according to 
the National Institutes of Health (Winters, K., & Kaminer, Y. (2008).  CRAFFT is an 
acronym for the words car, relax, alone, forget, friends, trouble, which are, the key 
words in the six questions of the screening tool: 
1.  Have you ever ridden in a CAR driven by someone (including yourself) who 
was “high” or had been using alcohol or drugs?  
            2.  Do you ever use alcohol or drugs to RELAX, feel better about yourself, or fit  
 in?  
            3.  Do you ever use alcohol or drugs while you are by yourself, ALONE? 
            4.  Do you ever FORGET things you did while using alcohol or drugs? 
            5.  Do your family or FRIENDS ever tell you that you should cut down on your 
 drinking or drug use? 
            6.  Have you gotten into TROUBLE while you were using alcohol or drugs? 
(Centre for Adolescent Substance Abuse Research (CEASAR), 2016; 
American Academy of Paediatrics, 2011).   
This tool can either be self-administered or clinician administered (NIH, 2016). 
In order to reduce the number of adolescents at risk for adverse effects of 
cannabis use, clinicians must be diligent in screening and identifying this particular 
group.  Health care providers need to be educated on how to implement the cannabis 
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screening tool along with knowing how to interpret these results.  This DNP project is 
focused on how to implement the CRAFFT cannabis screening tool to the adolescent 
population with the intent of identifying those at risk for the adverse effects of cannabis 
use.  
Problem Statement  
The nursing practice problem that will be focused on in this doctoral project is the 
adverse side effects cannabis has on the developing mind and body of our 
youth/adolescent population and how screening for SUDs can aid in preventing such 
adverse effects.  Toronto’s CAMH provides specific information regarding Ontario’s 
student drug use with a survey they administer annually.  CAMH administers this survey 
for social research at York University to grade 7 through 12 students across Ontario 
(CAMH, 2017).  When results of the 2016 survey are compared with the results from 
1990, there has been a marked increase in drug and alcohol use amongst youth (CAMH, 
2017).  CAMH’s (2017) most recent survey also shows a new trend relating to marijuana 
and how it is used with electronic cigarettes or vaping tools.  Five percent, or 35,000 of 
Ontario high school students surveyed admitted to using cannabis this way (CAMH, 
2017).  In Canada, these numbers include 12.2% or 3.4 million Canadians aged 15 and 
older (Statistics Canada, 2018). 
Another new way of using cannabis was as a synthetic form, referred to as spice 
or K2.  One percent of students had admitted to using it this way.  The total number of 
students who admitted to trying cannabis in one form or another was 203, 900 in 2015  
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(CAMH, 2017).  As the students progress through their high school journey so 
does the number of students who experiment with substances such as cannabis.  With the 
increasing use of cannabis among Ontario and Canada’s use comes the increase 
possibilities of risky behavior, such as driving under the influence. (CAMH, 2017). 
CAMHs 2015 survey reports that 1 out of 10 students have driven a car after using the 
illegal substance. (CAMH, 2017).   
When CRAFFT was used with students of the 2015 survey, 114,500 or 1 out of 6 
students proved to have a drug use problem, indicating that Canadian youth are ranked 
the highest users of marijuana use in developed countries (CAMH, 2017).  With the 
above data in mind, the importance of screening for those at risk of SUDs on a routine 
basis by health care providers becomes clear.  Being able to identify those at risk of 
harming themselves and potentially others will assist in decreasing the harm done to the 
developing brain associated with chronic cannabis use while avoiding psychosis, mood 
disorders, and respiratory conditions (CAMH, 2017). 
Purpose  
A dose-response relationship develops with the frequent use of marijuana use.  
Statistics Canada (2018) reported that, as teens increase their use of marijuana, their 
cognitive functioning and educational attainment decrease.  With the existence of medical 
marijuana laws and the increasing rates of legalization of marijuana in North America, 
teenagers’ access of this substance is further lowered as it becomes more mainstream in 
communities (Rotermann, 2015).  The focus of the practice problem is highlighting the 
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importance of screening for and addressing cannabis use, abuse, and addiction within the 
youth population to prevent unnecessary negative mental and physical effects.    
This quality improvement project consisted of an educational module to aid 
clinicians and other professionals with implementing the CRAFFT tool with cannabis 
users aged 21 or younger.  This learning module has illustrated how to interpret results 
and how to be aware of what the next steps are after the tool has been used to assess those 
at risk for cannabis use adverse effects. Identifying youth and adolescents who partake in 
cannabis use is an important task that nurses and other health care providers need to make 
part of their everyday practice to ensure that those who are at risk for cannabis adverse 
effects are provided counseling and treatment at the earliest intervention as possible 
(AAP, 2011).     
SUDs are an under diagnosed medical condition due to the lack of time, the lack 
of training on CRAFFT outcomes, the need to triage medical conditions that have a 
higher priority, and the lack of treatment resources (Winters, K., & Kaminer, Y., 2008).  
When properly diagnosed with the implementation of a cannabis screening tool such as 
CRAFFT, psychiatric comorbidities along with psychosocial maladjustment disorders 
can possibly be identified earlier. (Winters, K., & Kaminer, Y., 2008).   A solution to this 
ever-growing problem is to provide adequate training on screening and assessing youth 
substance use, abuse and dependence in medical and nursing schools (Winters, K., & 
Kaminer, Y., 2008).  
If this problem is not addressed in the near future Canada’s substance abuse will 
continue to rise.  With the rise of SUDs comes an increase in adolescent death rates, 
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which are currently around 47,000 per year (Teen Challenge, 2015).  According to Teen 
Challenge (2015) it costs Canada’s federal government $8 billion annually for health care 
related to substance abuse.  The top four substances of abuse identified are: alcohol 
(58%), cannabis (25%), prescription pain relievers (17%), and tobacco (11%).  Sixty 
percent of Canada’s drug users are between 15 and 24 years of age. (CCSA, 2016; Teen 
Challenge, 2015). 
Nature of the Doctoral Project   
New substance use screening guides such as RNAO’s Best Practice Guideline 
(BPG): Engaging Clients Who Use Substances have recommended that all nurses inquire 
about alcohol and substance use with every patient (RNAO, 2015).  This document aids 
nurses and other primary care providers in identifying substance users while allowing for 
safe, effective charting and improving patients’ health and wellbeing.  By applying a 
simple substance use screening tool (CRAFFT), drug users can be identified and offered 
access to interventions and counseling, as set out with RNAO’s BPG (RNAO, 2015).  
This guide is set up to aide in easing the nurse into feeling comfortable with addressing, 
SUDs (Zych, 2015).   
The major outcomes of the BPG (RNAO, 2015) are to (a) provide education for 
nurses who are working amongst a population with SUDs, (b) provide harm reduction 
into their organizations patients by addressing SUDs, and (c) set up undergraduate nurses 
with the theories need to be applied to clinical practice to provide appropriate nursing 
care to substance users (RNAO, 2015). 
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The CRAFFT cannabis screening tool was introduced to a group of primary 
health care professionals as part of an educational session.  This session consisted of 
assessing the health care providers’ knowledge both before and after the presentation.  
The premise of the information session focused on how to properly implement and 
interpret the results of this tool.  Having understood the results of the CRAFFT tool, next 
steps were mentioned so the health care providers know how to proceed with anyone who 
has been identified with substance use concerns.  A pre- and posttest was utilized in this 
educational session to assess the knowledge base of the participants both prior to and 
after the session has been completed.   
The CRAFFT screening interview could be available in the client’s electronic 
medical record (EMR).  This would allow for the information on how often the substance 
use tool is being used with the target population and if it is being implemented 
accordingly while meeting its intent.  The importance of assessing for and addressing this 
particular substance use disorder in the young adult population is of utmost importance, 
and having health care professionals engage in this type of evidence based practice is 
essential.   
The Liberal Party of Canada plans on legalizing, regulating, and restricting 
marijuana in the near future, which may easily lead to increased use in the younger 
population (Liberal Party of Canada, 2018).  This federal government’s reasons for 
legalizing cannabis is to attempt to prevent young people from using it while decreasing 
the number of criminal records with those who possess small amounts of the substance 
and decreasing involvement in the illegal drug trade (Liberal Party of Canada, 2018). 
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This new development will bring new laws relating to punishments of those who provide 
cannabis to minors, driving under the influence of cannabis, and selling this substance 
outside of the acceptable framework (Liberal Party of Canada, 2018).    
Data for this DNP project was obtained with a test being administered to the 
participants both before and after the modules were studied, in attempts of assessing the 
practitioner’s knowledge base on cannabis use in adolescents, the CRAFFT screening 
tool, and the impact cannabis has on the developing adolescent mind.  The data was kept 
in a locked drawer in a room with a locked door, protecting the privacy of the participants 
involved.  The results of this data were shared with the participants at the organization 
along with the DNP’s completed version of the project. 
Significance   
Primarily Canada’s youth and young adult population will be directly impacted by 
the implementation of this tool.  Identifying and addressing the needs of this particular 
population will have an immense impact on their overall mental and physical well-being.  
This type of identification will also have a direct impact on family members of those who 
are diagnosed with SUD.  Educational institutions involved with teenagers who are using 
marijuana on a daily basis will also have a stake in this type of tool implementation, as it 
will aid in identifying those at risk of the adverse effects of cannabis use.  This tool can 
also be used in educational settings by the medical team, along with emergency rooms 
where practitioners would encounter teens who may be under the influence at their time 
of triage (Kelly, 2014). 
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This doctoral project will contribute to nursing practice by aiding in disease 
prevention and health promotion by seeking out and identifying those at risk of the 
adverse health effects of cannabis.  Medical and nursing students can be aware of these 
particular screening tools while they are in their clinical settings and use them routinely, 
similarly to the way alcohol assessments are obtained with questionnaires or how the 
trans theoretical model/stages of change is used to assess for smoking cessation readiness 
(Ewing, 1984; Prochaska, J., & DiClemente, C., 1986). 
The CRAFFT cannabis assessment tool can be used in many settings including a 
primary health care setting.  For instance, adolescents and young adults who use cannabis 
can have this screening tool administered on them in settings such as: schools, jails, 
emergency rooms, specialized camps, or other settings where they receive medical care.  
This tool can be implemented in 6 minutes and is available for free online.  The barriers 
to using this tool are quite low considering that it is also available for use in different 
languages, including English, Chinese, French, Spanish, Russian, and eight other 
languages (CEASAR, 2016). 
Summary   
This project focused on the importance of screening for cannabis use, which has 
been proven to have a significant place in nursing practice for many reasons.  Identifying 
potential or existing adverse effects of cannabis use is extremely important in attempting 
to preserve patients’ physical and mental health.  Broyles, an assistant professor at the 
University of Pittsburgh and Health Scientist at the VA Pittsburgh Health care system, 
explained how nurses have a direct contact with patients and therefore have a pivotal role 
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in health education and health promotion as they are the largest body of health care 
providers (Vimont, 2011).   
As cannabis becomes more readily available to youth with the legalization of the 
substance, the potential adverse effects cannabis has on the developing body and mind 
will only increase as the barriers are removed in society (CAMH, 2017).  Implementing a 
screening tool, similar to the way the CAGE questionnaire or the transthoretical model 
are used for screening other substances, will aid in identifying those at risk for adverse 
effects of marijuana abuse.  Also having the tool easily available within the clients’ EMR 
will allow for easy accessibility and implementation.  Providing the education needed to 
nursing and medical schools to ensure that practitioners are versed in using this tool will 
prove to be paramount in obtaining the goal of assessing for cannabis use, misuse, and 





Section 2: Background and Context 
Introduction 
Screening for cannabis use and abuse in the adolescent population is essential in 
attempting to delay or avoid any long-term effects cannabis can have on a maturing mind 
and body.  This DNP project is also occurring at an essential time in the medical 
landscape as the legalization of cannabis is occurring in different locations across North 
America at a rapid rate.  Early identification of young adults and teenagers who are at 
risk for adverse health effects of marijuana can aid in the prevention of unnecessary side 
effects which can lead to a undesirable outcome both during their adolescent 
development and also later in their lives.  The routine implementation of a cannabis-
screening tool, such as the CRAFFT, has been proven to aid significantly in identifying 
those youth at risk for SUD and adverse effects of cannabis (Winters, K., & Kaminer, Y., 
2008).  Educating health care providers on how to use and interpret the CRAFFT tool 
with the intent to identify those at risk for SUD is the focus of this particular DNP 
project.   
Concepts, Models, and Theories   
The CRAFFT substance abuse screening tool aligns well with Rotter’s social 
learning theory and Merton’s concept of anomie.  Rotter’s problem behavior theory is 
based on a social-psychological conceptual framework and Merton’s concept of anomie 
(Jessor, 2017).  Problem behaviors can be thought of as behaviors that are considered 
undesirable, problematic, or concerning by society as a whole.  It is unacceptable 
behavior that may have consequences as set out by our governing bodies and overseen by 
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authoritarian institutions (Jessor, 2017).  The theory’s premise is that one’s behavior is a 
direct result of the interaction that takes place between a person and his or her 
environment (Jessor, 2017).  In Rotter’s social learning theory, learning can be thought of 
as behavior that is coupled with the study of personality (Rotter, 1972).  One is more 
inclined to seek out a positive stimulation than an unpleasant one, which according to 
Rotter (1972) is the empirical law of effect: People are driven by the desire to reach 
positive goals instead of being driven by a desire to avoid punishment.  Rotter’s theory is 
comprised of four main components:  
1. Behavior potential, which is the likelihood of engaging in a particular 
behavior in a specific situation. In a given situation, multiple behaviors can 
occur, however it is also personality that will determine the behavior that is 
displayed that will attain one’s highest potential.    
2. Expectancy, which is the probability that a behavior will lead to a particular 
outcome.  Strong expectations will lead one to behave in a particular way in 
order to reach a desired outcome.  These particular expectations will come 
from one’s past experiences and the more the behavior is reinforced then the 
stronger the expectation of that behavior will have.  It is important to note 
that in order for a particular behavior to be reinforced it doesn’t have to be 
experienced first hand; it can also be witnessed for it to have an effect on 
one’s behavior.   
3. Reinforcement value, which is the desirability of the positive outcomes.  
Desired outcomes have a much higher reinforcement value than do undesired 
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outcomes, or outcomes that are avoided.  One’s behavior is strongly 
influenced by desired outcomes; for example approval, love, or rejection are 
powerful influences on one’s behavior.  Desirable social outcomes have a 
profound effect on one’s behavior and therefore on how a person behaves, 
which is also very subjective.  With the thought of behavior, personality, and 
desired outcome Rotter has a predictive formula to his theory.  The predictive 
formula is as follows and this makes up a predictive formula for behavior: BP 
= f (E & RV), where BP = Behavior potential, E = expectancy, and RV = 
Reinforcement value.  Hence, one can think of the likelihood of someone 
acting in a particular way as a function of the probability that the particular 
behavior with lead them to a desirable outcome.  
4. Psychological situation, which is that each person’s experience of the 
environment, is unique.  It is therefore each individual interpretation of the 
environment that provides them meaningful and desirable behavior. (Rotter, 
1972). 
Rotter’s (1972) SLT holds that behavior is driven by positive reinforcements that 
are internalized by the individual and are specific to each person separately.  Cannabis 
use among adolescents can therefore be thought of behavior that is sought after due to the 
desired outcomes experienced by its users.  The outcomes cannabis users experience 
reinforce this particular behavior and are continued for the sought-after effects, as 
demonstrated by teens with SUD.  According to the empirical law of effect, behavior that 
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leads to positive stimulation is therefore a driving force behind teenage cannabis users’ 
desired outcome (Rotter, 1972).    
Relevance to Nursing Practice   
Substance abuse has proven to be a major health problem around the world 
(United Nations Office on Drugs and Crime, 2018).  The United Nations Office on Drugs 
and Crime reported that over 5% of the world population had used an illicit drug in 2010, 
with 27 million people (0.6%) in the world qualifying as problem drug users (UNODC, 
2018).  Treatment for those afflicted with drug problems equates to 200-250 billion 
dollars of the global gross national product (UNODC, 2018).  In order to address this 
high global medical expense, preventative measures must be put in place, starting in the 
primary care arena.  Researchers have found a high correlation between those teenagers 
who use drugs at a young age and adults who become drug abusers (National Institute on 
Drug Abuse, 2014).  The United nations Office on Drugs and Crime (2018) also explains 
how the high number of accidents and intentional fatalities related to drug and alcohol 
use among the world’s youth, aged 15-24 year olds, is the leading preventable cause of 
death.  The high rate of drug use within the teen population is also correlated to a high 
risk for scholastic underachievement due to the devastating effects on one’s memory and 
intellectual abilities, delinquency, teenage pregnancy and depression (Chakravarthy, 
2013; Crocker, 2015; NIDA, 2014).   
To avoid these types of negative health outcomes, preventative health measures 
must be at the forefront of health care delivery, especially in the primary care settings 
(Crocker 2015; NIDA, 2014).  The goal to reducing unnecessary and avoidable drug-
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related events is to reduce the number of risk factors associated with this by increasing 
the protective factors for these vulnerable teenagers.  NIDA (2014) explains how 
preventative measures would involve community leaders including doctors and nurses to 
implement interventions that would aid in decreasing adolescent substance abuse rates.  
By targeting modifiable risks and by enhancing protective factors through the health care 
programs, these goals can be achieved (NIDA, 2014).  The adolescent periodic health 
exam is an ideal time to inquire about drug use and abuse as well as implementing a 
standardized drug-screening tool to aide nurses and allied health care providers in 
identifying those at risk for drug abuse (NIDA, 2014).  Once any risks are identified, the 
nurse can then assess the severity and then set up an intervention or treatment option 
(Winters, K., & Kaminer, Y., 2008).  Nurses have the privilege of being able to intervene 
with appropriate assessment and interventions as suggested by the American Academy of 
Paediatrics (AAP) routine screening mandate for all teens.  AAP suggested that CRAFFT 
has proven to be an appropriate measure in meeting these protocols (Croker, 2015).  
Barriers that have been identified thus far as to why SUD screening tools have not 
been used include insufficient time, lack of knowledge on how to screen for substance 
abuse, lack of training in addressing the positive screens and managing teen substance 
use problems, triaging competing medical conditions, lack of treatment resources, and not 
being familiar with the screening tools (Croker, 2015; Subramaniam & Volkow, 2014; 
Tai, 2012; Winters, K., & Kaminer, Y., 2008).   
The US Preventive Services Task Force has deemed screening and intervening 
substance use problems among teens as insufficient (Winters, K., & Kaminer, Y., 2008).  
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There has not been enough clinical trials in the pediatric settings either as this poses some 
problems with confidentiality (Subramaniam & Volkow, 2014).  With research lacking in 
this area, SUD is poorly diagnosed by primary care providers and drug abuse treatment 
referrals to the appropriate parties are therefore not being done, leaving less than 10% of 
patients who qualify for treatment being referred appropriately (Levy, 2014).  This gap in 
services between general medical care and the lack of preventative medicine in primary 
care for substance abusers contributes to under detection of substance use problems (Tai, 
2012).  These barriers should be addressed and supported with preventative services with 
the backing of the Patient Protection and Affordable Care Act 2010 (United States 
Senate, 2010).   
A suggestion to aide in minimizing the lack of identification of drug abusers is to 
incorporate the standardized screeners for substance use into the patient’s electronic 
health records (EHR).  Patient Protection and Affordable Care Act 2010 in the United 
States has allocated funding to address substance abuse services and treatment (United 
States Senate, 2010).  Paired with the HITECH Act, which encourages clinicians to 
provide efficient and comprehensive care via the EMR (preventive services, treatment, 
monitoring and management of chronic disease).  Having drug abuse screening and 
assessment tools easily assessable in the EMR to be used with each patient will aide in 
achieving the goals set out by the AAP (Tia, 2012).   
Teens would be asked about substance use, and then administered the CRAFFT 
tool to stratify their risk level, as per the Screening with the Brief Intervention and 
Referral to Treatment (SBIRT) (Substance Abuse and Mental Health Services 
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Administration, n.d.).  All adolescent teens should be screened (AAP recommendations) 
at all visits with appropriate follow up and referrals. These visits all are tracked on the 
EMR.  To achieve this goal, individuals must be identified first through screening 
practices, as CRAFFT is able to do.  Data from clinical recommendations urge 
researchers to address this particular issue relating to drug use and disorders among teens 
(Tai, 2012). 
Results for SBIRT for substance abuse is critical for adolescent health outcomes, 
however not many studies have been done on its implementation (Sterling, 2015).  There 
are multiple national and international organizations that support SBIRT in primary care 
offices on the knowledge gained about how the tool is able to identify those at risk 
(Sterling, 2015).  Models can be developed and used in order to support SBIRT as 
recommended by AAP (2011).  To date there needs to be more research on pediatric 
SBIRT implementation and training clinicians on how to do this will lead to a great 
outcome on adolescent drug use screening and intervention (Sterling, 2015).   
Implementation of the CRAFFT screening tool via an EMR will definitely aide 
health care practitioners in assessing for substance use/abuse amongst the adolescent 
population.  This valuable assessment will assist in the prevention of avoidable accidents 
and overdoses when identified early.  
Local Background and Context   
With the prevalence of adolescent drug use leading to abuse and other health 
concerns, nurses can play a pivotal role in screening teens for drug use, drug abuse and 
potentially substance abuse disorders. Winters & Kaminer (2008) believes that a process 
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should occur in the health care arena that would aide in identifying teenagers for 
substance abuse disorders with the implementation of a screening tool such as the 
CRAFFT screening tool.  After identifying teens with substance abuse disorders then a 
comprehensive assessment of the problem would need to be arranged to assess the 
severity an individual is experiencing.  Finally, there would be a treatment plan that 
would be discussed between the patient and the health care provider.  (Subramaniam, G., 
& Volkow, N., 2014).    
Validated screening tools should be used to assess the severity of drug use 
problems (Winters & Kaminer, 2008).  A tool that is considered to be favorable in this 
specific outcome is one that possesses strong psychometric properties, is simple to score, 
easy to administer and can be learned by simply reading a manual (Levy, 2014; Winter & 
Kaminer, 2008).  The 6-item CRAFFT screening tool meets all the above criteria and 
illustrated ease of use in a routine pediatric interview, which screened for alcohol, drug 
use and SUD (Levy, 2014; Winter & Kaminer, 2008).   The CRAFFT proved to be highly 
predictive of presence of SUD aligning with the Diagnostic and Statistical Manual of 
Mental Disorders - IV.  86% of the participants in this study had SUD which was 
determined by implementing a self-report.  It is therefore essential that formal training on 
SUD and how to screen for them be introduced while in medical or nursing schools.  
Both initial evaluation and a reevaluation to measure outcome of desired effects could be 
determined with the CRAFFT tool (Croker, 2015; Levy 2014; Subramaniam & Volkow, 
2014; Winter & Kaminer, 2008).  Pilowsky (2013) conducted a study to assess, which 
screening tool was most effective in identifying teen substance abuse and this resulted 
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with the CRAFFT tool being superior.  Teenagers preferred performing the screening test 
with paper and pencil or computerized questionnaires to interviews with a medical 
professional (Pilowsky, 2013).   
Nurses and other medical providers can also have a direct relationship between 
the public and political arena (White, 2015).  With the soon to be, legalized recreational 
marijuana in Canada, there is no better time then the present for nurses to execute their 
scope of practice and educate the general public about the effects marijuana have on 
one’s health, especially the health effects on adolescents and young adults (White, 2015).  
School nurses in grade schools and secondary schools can also make a significant 
impact on youth and teenagers by providing a substance abuse prevention program and 
screening program (Levy 2014; Pastestos, 2014).  Careful assessment and identification 
of risk factors will definitely aide in the prevention of substance abuse in the adolescent 
population, which can ideally avoid unnecessary health problems that can occur in their 
young adult lives (Pastestos, 2014).  Adolescent brains are highly vulnerable to drug use, 
including alcohol and cannabis use.  The effects that take place are both immediate and 
distant, effecting one’s neurocognitive function including effects on the emotional 
regulation system (Subramaniam & Volkow, 2014) 
Substance abuse must be addressed as soon as it is identified in all aspects of 
health care but especially in the primary care arena.  Developing brains are vulnerable to 
the devastating effects of THC and cannabinoids.  The devastating effects of drug abuse 
can lead to less productive and rewarding lives in adult life (Croker, 2015; Levy, 2014,  
Subramaniam & Volkow, 2014).  SUD leads to morbidity and mortality while 
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contributing to mental health disorders and negative social sequelae (Levy, 2014).  
Accidental death is another preventable side effect of drug use and abuse in the teen 
population.  Teen deaths are largely preventable as most are a direct cause of substance 
related motor vehicle accidents and overdoses (Levy 2014; Subramaniam & Volkow 
2014).   
American Academy of Paediatrics strongly advises that nurses intervene with all 
levels of drug use in the following ways:  (a) When there is no use reported then the 
patient should be praised for making such good decisions.  (b) Moderate risk individuals 
should be educated about the negative impact that drugs have on one’s health.  (c) Those 
as serious risk of abuse require a referral to a facility where treatment is available to 
them. (d) Very high risk cases would have to involve the patients guardians with or 
without the patients consent to ensure the person’s best interest was being addressed 
(Croker, 2015; Levy 2014).    
Institutional Context 
This proposal-learning objective that focuses on a learning module of how to 
properly implement the CRAFFT Cannabis Screening Tool to aid in the identification of 
those at risk for adverse effects of non-medical cannabis will take place in an Aboriginal 
Health Centre, which consists of two sites.  One site is located in Hamilton Ontario while 
the other is located in Brantford, Ontario.  This particular organization that has existed in 
these cities provided primary health care to families for over twenty years.  The primary 
care team working in these establishments consists of physicians, nurse practitioners, 
diabetic educators, registered dieticians, social workers; their respective colleges regulate 
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a naturopathic doctor and other auxiliary staff of whom.  (College of nurses of Ontario, 
College of Physicians and Surgeons, College of Registered Dieticians, College of 
Naturopathic Medicine, Ministry of Community and Social Work).  The above 
mentioned workers operate within a particular scope of practice that is mandated by their 
specific provincial colleges, which dictates the expectations each disciplinary should 
meet while providing health care to their patients.  The mission of this proposal is to 
ensure the health care professionals of the Aboriginal Health Centre understand how to 
identify adolescents at risk of cannabis adverse effects by screening those at risk at each 
primary care visit using a tool that is embedded in an EMR.   
Role of the DNP Student   
The DNP student’s preceptor was employed at the Aboriginal Health Centre and 
hence was used as the setting for the student’s practical experience.  This facility is 
comprised of approximately 1500 Aboriginals spanning the life span from newborns to 
the elderly.  Marijuana use is prevalent in this particular population and is especially 
commonly used within the adolescent age group.   
As a nurse practitioner assessing adolescents on a routine basis I know first hand 
that the social history assessment lacks a thorough assessment of illicit drug use.  
Documentation on an adolescent’s chart in this primary care setting currently simply lists 
use of any drugs under the social history component in the clients profile page.  While 
other substances, such as alcohol and nicotine use are quantified with tools such as the 
CAGE questionnaire and Trans theoretical Model which help stratify one’s risk of 
adverse health effects.  With the understanding of the importance of assessing cannabis 
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use among teenagers the health care providers will be equipped to implement a cannabis-
screening tool (CRAFFT) to aide in assessing an individuals risk for adverse effects.   
As a primary care nurse practitioner with a special interest in mental health, 
screening more thoroughly for cannabis use and abuse by implementing the highly 
recommended CRAFFT screening tool will aide practitioners in stratifying youth’s risk 
from substance use and or abuse (Canadian Pediatric Society, 2016).  AAP and the 
Canadian Pediatric Society (CPS) stand strongly behind this recommendation.  In fact the 
CRAFFT questionnaire recently has been included in the Greig Health Record for well 
teen visits (CPS, 2016). 
I am very motivated to ensure the CRAFFT tool is being used appropriately and 
effectively in the primary health care arena in attempts of identifying youth at risk for 
mental health adverse effects.       
Potential biases that I may have possessed are as follows, along with the steps that 
will be taken to address them as per Sarniak’s (2015) suggestions.     
1. Confirmation bias: defined as a researcher forms a hypothesis and uses the 
study’s participant’s information to confirm such belief.   In order to avoid 
confirmation bias, the researcher will need to continually reevaluate the 
respondent’s responses while assessing preexisting assumptions (Sarniak, 
2015).    
2. Culture bias: defined as assumptions founded on our cultural outlook.  
Minimizing this bias entails unconditional positive regard of cultural 
assumptions while avoiding ethnocentrism (Sarniak, 2015).  
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3. Question order bias: defined as having one question influencing another 
question.  How questions are worded and presented can have an effect ones 
thoughts, feelings and attitudes on questions in the study.  Ways to avoid this 
type of bias are to ask general questions over specific questions and positive 
before negative questions (Sarniak, 2015).   
Great efforts were used to eliminate any type of researcher bias, however 
sometimes bias is unavoidable.   
Summary  
With the legalization of cannabis use occurring vastly in North America, cannabis 
will become more readily available for recreational use for both adults and teenagers 
(Liberal Party of Canada, 2018).  Knowing the effects that cannabis has on the 
developing teenage mind, as presented earlier in this proposal, it is paramount that health 
care providers become diligent in assessing recreational cannabis use in teens.  A proven 
effective method of doing this is with the implementation of Cesar’s CRAFFT screening 
questionnaire as recommended by both Canada’s pediatric experts (Canada Pediatrics 
Society, 2016).  The current trends in primary care practice does not reflect an adequate 
assessment of drug use among teens is being captured partially because practitioners are 
unfamiliar with what tool to use and how to interpret results if used.   Introducing health 
care providers with the CRAFFT tool and educating them on how to use and interpret the 
results of this tool will allow for better identification of those at risk of cannabis adverse 
effects.  The next chapter will explain the methodology of how this particular pilot study 
will occur in the formerly described setting.   
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The undesirable health effects cannabis has on the developing mind and body of a 
teenager needs to be screened for and identified in a more efficient way by primary care 
providers, especially with the legalization of recreational marijuana on the horizon across 
Canada.  Screening for cannabis use with the CRAFFT screening tool is an effective way 
to identify those at potential risk for adverse effects of cannabis use.   
In this section, I will discuss how the practice focus question will be implemented 
in a designated health care center consisting of a multidisciplinary team that provides 
care to a young population who heavily use marijuana and other illicit drugs.  I also 
present a literature review to illustrate how the CRAFFT tool can be very effective in 
attaining the outcome of diagnosing SUD and identifying those who may be at risk for 
this diagnosis.  Finally, I will define how this information was analyzed and synthesized.   
Practice-focused Question   
Research has proven that primary care practices currently are lacking the 
implementation of an effective cannabis screening tool, such as the CRAFFT, for 
multiple reasons (Winters & Volkow, 2008).  The barriers for this screening tactic 
include lack of time, lack of knowledge, and lack of treatment providers (Pilowsky, D., & 
Wu., L., 2013).  However, with an education module and easy access to the CRAFFT 
screening tool, assessing youth at risk for cannabis use can be done much more 
efficiently than it is being done today. 
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Sources of Evidence 
The sources of evidence used to aid in addressing this practice-focused question 
are the PCPs that work at the health center where the DNP project will take place.  The 
number of teenagers and young adults these providers see on a weekly basis is quite high, 
except for the diabetic educators and dieticians.  Cannabis use in this particular group is 
considerably high, therefore making for a suitable location to perform this DNP project.   
Screening for cannabis use and abuse amongst the adolescent population is not 
done effectively in this health center, therefore the practitioners will benefit from being 
educated and made aware of the CRAFFT tool.  Proper use and implementation of the 
CRAFFT tool aided these health care providers in accurately assessing and diagnosing 
those with or at risk for SUD.   
Introducing PCPs to screening tools such as the CRAFFT substance use tool is the 
beginning stage of narrowing the gap in identifying teens at risk for SUD.  Once the 
PCPs are aware of how to screen for and interpret results of the screening tool, more 
comprehensive assessments can be performed in each qualified patient followed by an 
appropriate diagnosis and proper treatment initiation.  This simple, quick, and easy-to-use 
tool can be instrumental in starting a movement in attempting to lessen the burden 
cannabis is having on our youth population.   
Information was collected by this group of PCPs with a pretest and posttest 
(Appendix B) pertaining to cannabis use disorder among teenagers and youth population.  
The PCPs were educated about the CRAFFT tool and how to implement it and interpret 
the results.  The teaching module (Appendix C) explained how to access the tool in the 
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Nightingale on Demand documentation system on the health center’s EMR.  The 
evidence from the pre- and post-tests were used to analyze if the PCPs found this tool to 
enhance their assessment and treatment skills for SUD in youth.   
If screening for cannabis is not being done effectively in one health center then 
there are probably many other health centers in Ontario and Canada, that also need to be 
introduced to this highly effective screening tool.  Having the tool easily accessible in a 
health care office’s EMR, with an educational module to accompany it, will be a starting 
point of addressing the cannabis issue that exists among Ontario’s youth and adolescents.   
Published Outcomes and Research 
I conducted research for articles pertaining to cannabis use/abuse in teenagers 
with the use of the CRAFFT screening tools using the following databases and search 
engines: CINAHL, PubMed, Cochrane database of systemic reviews, ERIC, Health and 
psychosocial instruments, OVID, MEDLINE, PsychARTICLES, PsychINFO, and 
Google scholar.  The search terms used to find the relevant research were CRAFFT 
screening tool, CRAFFT, CRAFFT tool, cannabis screening tools, cannabis use, 
cannabis abuse, substance use disorder, marijuana, marijuana use, marijuana abuse, 
adolescents, youth, teens, and teenagers.   
Information was searched using the following search limits: 2005-til 2017 using 
peer-reviewed sources.  Once I had completed a literature review, I conducted an 
expanded search to include specific organizations, regulatory bodies, and guidelines, 
including evidence-based research.  This particular search was expanded to include 
searches for the behavioral model as explained by Rotter’s social learning theory.   
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The CRAFFT cannabis screening tool has been validated in a variety of 
populations and proven to be beneficial in diagnosing SUDs in adolescents by meeting 
the diagnostic criteria of SUD in the Diagnostic and Statistical Manual of Mental 
Disorders - IV (Cummins et al., 2003; Kandemir et al., 2015;  Knight, Sherritt, Shrier, 
Harris, & Chang, 2002; Subramaniam, Cheok, Verma, Wong, & Chong, 2010; Winters, 
2008).   
Clinical tools exist to aide PCPs in detecting alcohol-related problems and 
quantifying the risks of nicotine use with their patients, but little assessment is given to 
those who partake in recreational cannabis use.  Knight et al. (2002) developed the 
CRAFFT test for the exact purpose of identifying youth and young adults at risk of 
SUDS, which address abuse and use of cannabis.  This screening tool is especially useful 
and easy to administer in busy medical offices due to its ease of administration, quick 
scoring criteria, and simple recall of the screening tool questions (Kandemir et al., 2015; 
Knight et al., 2002; Subramaniam et al., 2010).  CRAFFT is a promising brief diagnostic 
tool to detect drug use disorders in youth.  American guidelines for adolescent preventive 
services recommends health care providers ask all adolescent patients about substance 
use routinely (Subramaniam et al., 2010).  Identifying youth at risk of SUDs could aid in 
the prevention of low quality of life and a life dependent on substance use (Cummins et 
al., 2003; Kandemir et al., 2015).  There have been numerous studies done using a variety 
of different populations that have proven that the CRAFFT tool aides in identifying 
adolescents at risk of substance use problems.     
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The CRAFFT screening tool is designed to recognize the degree of substance use 
over a 12-month period.  The CRAFFT tool divides substance use into the following 
categories: (a) no use in past year (b) any alcohol or drug use during the past year, (c) 
mild or moderate SUD, and (d) severe SUD (Levy 2014) 
Knight (2002) looked at 538 participants of a mixed race and ethnic minority 
groups and found 49.6% had never used marijuana, 23.6% occasionally used cannabis, 
10% had a problem with marijuana use, 9.5% abused cannabis and 6.7% were dependent 
on it.  In this particular study, the CRAFFT score strongly correlated with the DSM-IV 
substance use and substance abuse classifications, with a Spearmanns correlation 
coefficient of 0.72: P<.001.   CRAFFT scores of 2 or higher are used to identify an 
individual with a substance use disorder and a CRAFFT score of 1 identifies those with 
problem use.  A negative score indicates that no further testing is needed (Kandemir et 
al., 2015).  Levy (2014) conducted a study with 216 patients.  The CRAFFT tool was 
found to have a sensitivity of 100% and specificity of 84%, which validated the tool.   
AAP guidelines recommend further evaluation be done by a PCP whenever a teen 
has been identified with high risk substance use.  With SUD being poorly diagnosed by 
PCPs, the referrals for ongoing assessment and/or treatment is also poor.  The treatment 
outcomes for teenagers for SUD are less than 10% due to a weak screening phase for it.  
Implementation of the CRAFFT screening tool has proven in multiple studies to aid in 
increasing the diagnosis of those at risk for SUD (Cummins et al., 2003; Kandemir et al., 
2015; Levy et al.,  2014; Subramaniam et al., 2010). 
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Cannabis screening done in Asian, Turkish, American Native and other ethnic 
groups all identified the CRAFFT tool to have a sensitivity ranging from 0.76-0.99% and 
a specificity of 0.76 - 0.94. (Cummins et al., 2003; Kandemir et al., 2015; Knight et al., 
2002; Levy et al., 2014; Subramaniam et al., 2010) which coincides with Knight’s et al., 
(2002) original design of the tools ability to rule in or rule out a substance use disorder.   
Both the positive predictive value (PPV) and the negative predictive value (NPV) of the 
various studies amongst a mixed racial group and in a Turkish teen group were also 
comparable resulting in a PPV of 75% - 85% and a NPV of 91%-92.9% (Knight et al., 
2002; Kandemir et al., 2015).  
Validity of the substance use identification tool was not affected by one’s age, 
sex, race or language and was proven to be reliable and valid with an acceptable internal 
consistency to screen teenagers for problems related to substance use (Kandemir et al., 
2015; Knight et al., 2002).    
This well adapted screening tool was also used in a Singapore study amongst a 
multi-ethnic group of 23,000+ males as part of a military medical exam proving to be one 
of the first studies done in this population screening for substance abuse or dependence 
(Knight et al., 2002; Subramaniam et al., 2010).   Of this group of young men, 4764 of 
them were identified as having SUD.  The CRAFFT proved to have moderately high 
levels of internal consistency also in this study of Chinese, Malay and Indian men with an 
internal consistency of Cronbach’s a=0.73 (Subramaniam et al., 2010).  It was found that 
this tool was useful in screening for drug use in a group of low risk substance users.  The 
internal consistency was found to be a=0.73 which was similar to scores in studies with 
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different ethnic groups (a=0.68, a=0.81), (Cummins et al., 2003; Knight et al., 2002).  
The identification of substance users in this low risk group found that scoring 1 or more, 
instead of 2 or higher identified those at risk of substance use disorder (Subramaniam et 
al., 2010).   
In contrast to the low risk Asian population another study looked at a high risk 
group of American Indians and Alaskan Natives (Cummins et al., 2003).  In this 
particular population substance use problems are identified at a younger age, as early as 
11 years old so the tool can be used in prepubescent candidates if they are considered to 
be at risk for SUD.  An optimal cut point for drug use problems in this group was found 
to have a score of 3 or greater given the higher risk factors for SUD (Cummins et al., 
2003).  This particular study has proven that the tool is used appropriately among the 
Native adolescent population given a higher score be considered when diagnosing 
substance use problems (Cummins et al., 2003).  The CRAFFT screening tool can be 
used in multiracial and ethnic settings as it has been proven to identify youth and teens 
either at risk for SUD, or those who have SUD.   
Evidence Generated for the Doctoral Project 
Participants.  The number of participants who provided information for this 
study was 17: five family doctors, five nurses, two diabetic educators, four social workers 
and one registered dietician.  All participants involved in the project are English speaking 
and provided care to patients who could benefit from the implementation of this 
screening tool.  All of the above listed PCP’s have been employed with the company for 
at least two years or more, excluding one, who is a recent Nurse Practitioner graduate.     
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Procedures.  Information was collected with a paper version of a multiple-choice 
pre and posttest pertaining to cannabis use screening tools, specifically the CRAFFT and 
diagnosis of SUD.  (Appendix B) 
Protections.  Informed consent was obtained from all of the participants prior to 
engaging in the DNP project, while remaining anonymous.   The tests were locked in a 
drawer where only the DNP student had a key, and access to the information.  Once this 
project was completed, the information obtained from the participants were destroyed.  
Collecting data was not initiated until the Walden University IRB approved this doctoral 
proposal/project.     
Analysis and Synthesis   
The DNP student conducted a qualitative analysis of the information collected.  
Observations pertaining to the knowledge base of each participant before and after the 
CRAFFT screening tool was done.  Assessing if these particular health care providers 
found this module helpful or not was also gauged.  Future implementation of this tool 
was also inquired about and assessment of whether or not each provider found the 
CRAFFT tool to aid him or her in their assessments of cannabis screening tool was 
looked at.  There was opportunities for the participants to make comments or ask 
questions for clarification on the pre and posttest, which was helpful in capturing 
information that may have been missed.   
Summary 
The CRAFFT screening tool for cannabis use/abuse has proven to be an effective 
tool as evidence by Cummins et al., 2003; Kandemir et al., 2015; Knight et al., 2002; 
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Levy et al., 2014; Winters, K. C., & Kaminer, Y., 2008; Subramaniam et al., 2010.  
Implementation of this tool within medical practices EMR’s, where PCP’s have easy 
access will prove to have a positive outcome in providing better care to those with SUD.  




Section 4: Findings and Recommendations 
Introduction 
In North America, one of the leading health concerns amongst the adolescent 
population is the high rate of cannabis use and its adverse effects on the developing brain 
and body (NIDA, 2018).  In my nursing career I have noted PCPs to document cannabis 
use by simply noting “positive or negative”.  Some providers capture the amount used 
and frequency of use, but not many have been known to use a screening tool to capture 
the extent of each users risk for adverse effects (Stoner, 2016).  With the rate at which 
marijuana is being legalized across the United States and Canada, it is paramount that 
cannabis use in teenagers is not only recognized but also clinically assessed with the use 
of a valid tool such as the CRAFFT cannabis screening tool.  With the implementation of 
this tool, the potential of identifying youth at risk for adverse effects of cannabis use 
grows exponentially.  The tool aligns precisely with the DSM-IV SUD diagnosis criteria 
allowing PCPs to assess users risks more easily and readily (Winters, K., & Kaminer, Y., 
2008).  This assessment tool can be used similarly to the CAGE questionnaire for 
assessing alcohol (Ewing, J., 1984) use and to the “The 5A’s” (Agency for Healthcare 
Research and Quality, 2012) way of assessing smoking cessation.  
Educating youth and young adults about recreational cannabis and the effects it 
has on their growth and development is essential so that health care providers can attempt 
to prevent any short- or long-term effects the drug has on mental and physical health.  
Implementation of the CRAFFT cannabis-screening tool has proven to allow PCPs to 
detect substance users and the possible SUD.  Once teens have been identified with this 
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disorder, triaging and possible referral to treatment centers can be initiated. This 
Doctorate of Nursing project has focused on improving the quality of care that is 
provided at the health center by having this tool become an assessment tool that is used 
with all teenagers to find those who use cannabis and their risk for long-term effects.  
With the design of the CRAFFT tool reflecting the DSM-IV’s SUD diagnosis criteria, it 
definitely has a strong role in filling this gap in practice, especially since cannabis is 
going to be more readily available once legalized this July 2018 in Canada.   
Findings and Implications 
It was made evident in the execution of this project that none of the participants 
knew of or used the CRAFFT screening tool prior to reading about it in the learning 
module.  A significant finding in this study was that not one person had been using any 
cannabis screening tools to screen for cannabis use or abuse in the adolescent population 
they provided health care services to.  After learning about the CRAFFT screening tool 
all but one of the participants indicated that they would start to use the CRAFFT tool to 
screen for cannabis use in the adolescent/young adult population.  The pretest indicated 
that all of the participants’ current way of documenting their adolescent patients’ 
cannabis use was by indicating “cannabis use – positive” with a quarter of the 
participants further defining patients’ cannabis use by quantifying the frequency and 
amounts used.  Documentation of cannabis use without a screening tool has proven to 
lead to the misdiagnosis of those that may be at risk of SUD or cannabis overuse.  
Analysis of the posttest demonstrated that all but one individual who was not familiar 
with the CRAFFT screening tool would implement it in their practice with future 
36 
 
assessments.  Also 80% of the participants indicated that they had not been referring for 
SUD treatment but would do so if a score of 2 or more were obtained when using the 
CRAFFT screening tool.   
Given that the learning modules and tests associated with them were anonymous 
it was difficult to decipher who had completed the test and who had not.  Four tests were 
not completed, which may have been because two of the participants had resigned from 
the health center and may or may not have completed the pre- and posttests.  Some may 
have chosen not to participate if they found the information to be irrelevant to their 
current role at the health center.  Despite the unanticipated incomplete tests, the findings 
would likely not have been much different if all tests had been completed because 90% of 
the subjects agreed to use the CRAFFT tool and regarded cannabis use assessments in the 
teen population to be important.   
The findings of the Doctor of Nursing Practice project imply that once the health 
care providers had been introduced to and became acquainted with the CRAFFT tool, the 
majority would implement and use the tool.  If more individuals could be educated about 
this particular screening tool, then more adolescent cannabis users could potentially be 
identified for being at health risks with ongoing use of cannabis.  One suggestion for 
implementation of the CRAFFT tool is to make it available for use in EMR templates, 
where it can be easily embedded into documentation when assessing teens with a history 
of cannabis use.  As the CRAFFT tool becomes more popular and its use increases, 
proper diagnosis of SUD will most likely increase accordingly.  The increased 
recognition of SUD will have a profound effect on communities as the long-term adverse 
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effects of cannabis begin to decrease.  If those at risk are being recognized early in their 
substance use habits, then ideally better outcomes will result with each cannabis user.    
Recommendations 
This DNP project is recognized as being one of quality improvement.  This 
project is focused on improving health care outcomes by assessing for and identifying 
any teenager or young adult with current or history of cannabis use.  This is recognized as 
improving acute and chronic conditions outcomes.  
The recommendation that has been suggested to address the gap in practice as 
previously discussed, is to have the CRAFFT screening tool embedded into the EMR so 
its template can be easily accessed and made a part of the patients encounter note.  This is 
done with a click of a button avoiding the need to search the web or search for paper 
copies that later have to be scanned into the EMR.  As new employees are hired, part of 
their orientation could acquaint them with the current templates available on our EMR 
system, highlighting the CRAFFT screening tool as cannabis use is considered to be high 
within our adolescent population.   
Strength and Limitations of the Project 
This doctoral project proved to benefit those who use cannabis and are at risk for 
adverse effects of cannabis use.  It also highlighted the need to educate health care 
providers about the importance of using a cannabis-screening tool such as the CRAFFT. 
Identifying cannabis users who are at risk for the adverse effects of this substance is 
paramount in the prevention of long-term consequences of its use.   
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The project’s limitations were the small number of candidates who were available 
to gather the information from.  It would have also been beneficial to be able to report on 
the number of users who started to implement the tool if time permitted.  
Recommendations to be made from this study are having future studies done in a similar 












Pretest questions   Positive responses  Negative responses 
What is the CRAFFT tool?       Yes         0 responses    No     10 responses 
Do you use a cannabis    Yes         0 responses       No     10 responses 
Screening tool?_____________________________________________________ 
What ages do you screen?    13-16      0 responses 
        17-21     1 response 
        22-26     0 responses 
        All ages    6 responses 
        No ages   3 responses 
Any referrals for cannabis     Yes      2 responses   No   8 responses 
Use or abuse? 
If yes to referring how many    0          4 responses  3 didn’t respond 
have you referred in past     1-5       2 responses 
year?      6-10     0 responses 
       11-15   0 responses 
               16-20    0 responses 
               21-25    0 responses 
               26-30    0 responses 
               30+       0 responses 
Ok for teens to use cannabis       Yes       3 responses     No    7 responses 
to help them sleep, or calm  
their anxiety? 
________________________________________________________________________ 
Current documenting        With a tool?    0 responses   Positive or negative? 
Method?                    10 responses 
Is teen and cannabis use a         Yes    8 responses    No   2 responses  
health problem? 
 









Posttest questions  Positive responses  Negative responses________ 
Do you know what the Yes         10 responses   No    0 responses  
CRAFFT tool is? 
What does the pneumonic Right     10 responses  Wrong?   0 responses  
CRAFFT stand for? 
Would you use a cannabis Yes       9 responses    No    1 response 
tool in your practice? 
What age do you use the  11-15    1 response 
CRAFFT tool?  16-20    1 response 
    21-24    0 responses 
    All ages  7 responses 
    No ages     1 response 
What score on CRAFFT do   0               0 response 
you need to refer for  1      1 response 
treatment?   2     7 response 
    3     2 responses 
Ok for teens to use cannabis Yes           3 responses No  7 responses 
for any circumstance? 
How to document cannabis  With a tool?     8 responses Positive or negative 







Section 5: Dissemination Plan 
I am planning on presenting this project and the importance of using the CRAFFT 
screening tool to the health care organization where I work at a future monthly staff 
meeting.  The tool itself will be downloaded, added to our current EMR and be readily 
available to all health care providers to use very conveniently when assessing cannabis 
use in adolescents.  A CRAFFT tool template will therefore be easily accessible in any of 
the client’s encounters of the patient’s charts, thus making it very easy to access and use.  
If for some reason the electronic chart was unavailable there will be access to the online 
electronic version that can easily be down loaded, printed off and then scanned onto to 
the patients chart.  Finally the fully documented written DNP report can be made 
available to the stakeholders of the company if they are interested in learning more about 
the project.   
The CRAFFT cannabis-screening tool can be used in a variety of different 
settings where adolescents and young adults access health care or health education.  The 
tool is very easy to access and only takes a few minutes to complete.  Some places that 
may find the implementation of the screening tool very convenient and suitable include: 
doctor offices, community health centers, Aboriginal Health centers, sexual health 
clinics, grade school or secondary school medical facilities and university health 
campuses.  An ultimate use of this tool would be to have all electronic medical record 
companies (Pikinji, NOD, PPS, etc.) have this tool embedded in its assessment templates 
making it available to all its users at any time.   
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Analysis of Self 
I have always thought as myself as a scholar, diligent practitioner and project 
leader or manager on a small scale during different aspects of my nursing career.  
However, now having almost completed my DNP, I can definitely say that this self-
image of scholar, practitioner and manager has definitely come to fruition.  I clearly see 
my future career roles incorporating projects requiring the change agent that I have now 
become.  Taking on quality improvement projects within the organization that I currently 
work in is beginning to occur and lends very well to my new expanded role for making 
change.  Another future goal that will come to life with the completion of my DNP is 
having the opportunity of becoming a professor of nursing, the next logical step forward 
from being a nursing instructor, of which I am today.  Finally, having gone through the 
doctorate program it has allowed me to become a better evidenced based practitioner as 
well as allowing me to learn about what other research nurses are bringing to the practice 
front.  This has been a real eye opening experience, which I have enjoyed immensely.  I 
will be forever grateful for having completed this program and enhancing the way I 
deliver nursing care, concepts, assessments or treatments, be it in a classroom, an exam 
room or clinical field.   
To date, this DNP program, including the project completion, has been one of the 
biggest challenges of my career.  When I was starting out on this journey I was excited, 
fearful and very anxious.  However, these feelings were not foreign to me, as when 
compared to the feelings I experience with most things that are new to me I seem to 
recognize these very similar feelings that accompany me at the start line.  The most 
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challenging part of participating in this project was spending most of my time doing 
school work opposed to spending time with friends and family and missing out on many 
social gatherings.  Sacrificing my time from my loved ones in order to advance my career 
and professionalism was a commitment that I hadn’t expected to be as grueling and as 
time consuming as it was. The past 5 years that I have spent on this project has allowed 
me to grow as a researcher, gain patience, learn discipline, communicate with professors 
and chair members while guiding me in the direction towards the final stage of the 
program.  I have so much to be thankful for and there has been numerous lessons learned.    
Summary 
Given the current landscape of 12.2% (3.4 million) of Canada’s youth and young 
adult population (Statistics Canada, 2012) being accountable for the 47, 000 annual drug 
related deaths and contributing to the 8 billion dollar substance abuse medical expenses 
demonstrates the need for action.  Of the 25% of teenagers and young adults who are 
using marijuana (CCSA, 2016) how many are being appropriately screened for substance 
abuse and how many more youths are being missed by not screening for substance abuse 
with the CRAFFT screening tool as suggested by both the American and Canadian 
Pediatrics experts (CPS, 2016). 
With the strong evidence of the effects cannabis has on its users it is health care 
providers clinical responsibility to be assessing and identifying those youth and young 
adults who put their health at risk from using cannabis.  By implementing the cannabis-
screening tool, such as the CRAFFT, substance use disorders in young adults can be 
identified early and interventions can be started in attempts of avoiding any long-term 
44 
 
consequences.  The legalization of cannabis that is to occur in Canada on July 1, 2018, 
will definitely allow for an increase in availability of this drug to adolescents, which will 
more than likely have an impact on its current 60% of accounted young adult users in the 
country (Statistics Canada, 2012).   
Canadian youth are ranked the highest users of cannabis in developed countries.  
1 out 6 students are diagnosed with a drug use problem when the CRAFFT tool was used 
exemplifying the tool’s ability to identify those at risk for marijuana’s adverse effects. 
(CAMH, 2016).  Levy et al., (2014) reminds us of how SUD is poorly diagnosed by 
health care providers allowing for missed opportunities to address a teenagers substance 
use concerns.  When screening for substance abuse with the CRAFFT tool in teenagers 
and young adults at all visits, paired with tracking these results on the patients EMR, the 
goal of screening practices will be obtained as set out by the American Academy of 
Pediatrics (2011).  By implementing the 6-item CRAFFT tool at routine adolescent visits 
substance use disorders won’t be misdiagnosed or missed (Levy et al., 2014; Winters, K., 
& Kaminer, Y., 2008).   
It the responsibility of nurses to be aware of the health concerns of our patients.  
Knowing the prevalent substance use that confronts our youth is one of these concerns.  
Having the ability to implement the current research in attempts of bettering our client’s 
health is at the forefront of our daily practice.  It is therefore most appropriate for nurses 
and other health professionals to be implementing the CRAFFT screening tool in our 
current practice with the end goal of identifying those youth at risk for substance use 
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The CRAFFT Screening Questions  






During the PAST 12 MONTHS, did you:              No    Yes 
1. Drink any alcohol (more than a few sips)?         
2. Smoke any marijuana or hashish?         
3. Use anything else to get high?         
“anything else” includes illegal drugs, over the counter 




 Part B No Yes 
1. Have you ever ridden in a CAR driven by someone 
(including yourself) who was “high” or had been 




2. Do you ever use alcohol or drugs to RELAX, feel 
better about yourself, or fit in?    
3. Do you ever use alcohol or drugs while you are by 
yourself, or ALONE?    
4. Do you ever FORGET things you did while using 
alcohol or drugs?   
5. Do your FAMILY or FRIENDS ever tell you that you 
should cut down on your drinking or drug use?   
6. Have you ever gotten into TROUBLE while you were 



















ANY         
(A1 to A3), 
answer 




NO to ALL  







Appendix B: Pretest 
Please circle the most appropriate answer, may circle more than one answer. 
1.  Do you know what the CRAFFT tool screens for?                  Yes   or    No 
2.  Do you currently use a cannabis-screening tool in your practice when assessing 
adolescents/youth for substance use?        Yes   or   No 
3.  In what age group do you screen for cannabis use/abuse? 
 13-16,   17-21,  22-26,   All ages.  No ages.   
4.  Have you referred anyone with cannabis use/abuse for treatment?   Yes or No 
5.  If yes to above question how many people would you refer in the past year? 
 0,      1-5,       6-10,      11-15,      16-20,     21-25,     26-30,     30+ 
6.  Is it acceptable for teenagers to use cannabis to help them sleep, or to calm their  
 anxiety?     Yes or No 
7.  How are you currently documenting a patient’s cannabis use?   
 With a tool?       
 Documented amount being used?       
 Indicating cannabis used – positive. 





Appendix C: Posttest 
Please circle the most appropriate answer, may circle more than one answer. 
1.  Do you know what the CRAFFT tool screens for?                  Yes   or    No 
2.  Does the pneumonic CRAFFT stand for: 
 Car, Relax, Alone, Forget, Friends and Trouble? 
Car, Restless, Agitated, Family, Fun and Trouble? 
Cancer, Relax, Anxious, Forget, Friends, Trouble? 
2.  Would you use a cannabis screening tool in your practice when assessing  
adolescents/youth for substance use?         Yes   or   No 
3.  In what age group should the CRAFFT tool be used? 
 11-15   16-20  21-24    
 All ages listed.   
 None of the ages listed.   
4.  When is referral for SUD appropriate according to the CRAFFT tool results?  
 Score of 0,             Score of 1,             Score of 2,                Score of 3 
6.  Is it acceptable for teenagers to use cannabis in any circumstance? 
  Yes or No 
7.  How will you document a teen/youth cannabis use?   
 With a tool?       
 Documented amount being used?       









PSP Child & Youth Mental Health Module 
 
Substance Use Assessment 
 
Adolescence is the time during which most individuals first experience exposure to alcohol or 
other substances. Based on the scientific evidence, we know that the brain continues to 
develop throughout adolescence and into young adulthood, and insults to it during this period 
may result in unwanted, negative impacts both short and long-term.  Substance misuse and 
substance abuse then become important issues for the health of young people.  
 
Screening for substances use should be part of general health assessments for adolescents. 
Although every adolescent should be screened for substance use, there are some red flags that 
should trigger a more comprehensive assessment.  These are:  
 
 
x Adolescents who present with substantial behavioral changes  
x Adolescents who present to emergency medical services for trauma 
x Adolescents who present medical problems such as accidents, injury, or 
gastrointestinal disturbance 




Screening for substance use/misuse/abuse provides an opportunity for psycho-education about 
the risks of substance use (i.e., alcohol related car accidents are the number one cause of death 
in adolescents, psychosis risk with marijuana smoking) and an approach to safe and moderate 
use of alcohol. 
 
For those youth  whose substance use is harmful or putting them at risk for negative health or 
social outcomes,  screening opens an opportunity for referral to specialized treatment 
programs that can provide them with the comprehensive evaluation and interventions that 
they require.  While waiting for the teenager to get the specialized attention: monitor for self 
harm and suicidal behaviours; educate about the possible negative outcomes of substance 
misuse; provide support to family members and be available in crisis situation.  
  
A parsimonious approach to substance use screening in adolescent is the application of the 
CRAFFT screening tool (CRAFFT = mnemonic acronym of first letters of key words in the six 
screening questions). The CRAFFT is a valid, reliable, and developmentally appropriate tool.  
 
When using the CRAFFT, begin by asking the adolescent to answer the following questions 
honestly and reassure him/her that the answers will be kept confidential within the reasonable 
limits to confidentiality addressed (see page 7). 
 






                                                        
 
C -  Have you ever ridden in a CAR driven by someone (including yourself) who was "high" or had 
been using alcohol or drugs?  
R -  Do you ever use alcohol or drugs to RELAX, feel better about yourself, or fit in?  
A -  Do you ever use alcohol/drugs while you are by yourself, ALONE?  
F -  Do you ever FORGET things you did while using alcohol or drugs?  
F -  Do your family or FRIENDS ever tell you that you should cut down on your drinking or drug 
use?  
T -  Have you gotten into TROUBLE while you were using alcohol or drugs?  
 
Another thing to have in mind when screening or substances in adolescents is that substance 

















Let’s be clearer with words - Drug or substance consumption can be categorised into:  drug use; 
drug misuse; drug abuse and drug dependence. The latest is rarely seen during adolescence as 
it takes many years to develop.  
 
 
  x Use -  is defined as taking a drug in such a manner that the sought-for effects are 
attained with minimal hazard 
x Misuse - refers to inappropriate use of prescribed or non- prescribed substance.  
  x Abuse - repeatedly and willfully use of a substance that result in repeated adverse social 
consequences related to drug-taking—for example, interpersonal conflicts, failure to 





The CRAFFT is not a diagnostic tool but the higher the score on the CRAFTT the greater the 
probability for a Substance Use Disorder.  However, the key clinical issue is not whether the 
young person meets diagnostic criteria for a Substance Use Disorder but what harm may be 
likely to happen as a result of substance use.  The clinician should use the young person’s 
answers to this tool to explore the impact of substance use on his/her life and decide on the 
nature, type and immediacy of the intervention needed (if any) based on that further 
information.  If a Substance Use Disorder is suspected or if the young person is demonstrating a 
high risk of harm related to substance use, a referral for a mental health and substance abuse 
assessment is recommended. 




Used with permission from Tools & Resources --- GPSC.  Learning Modules.  Adult 
Mental Health Tools & Resources.  Retrieved from http://www.gpscbc.ca/what-we-
do/professional-development/psp/modules/child-and-youth-mental-health/tools-resources 
On June 13, 2017.    
 
 
